These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32933490)

  • 1. Distribution pattern of amino acid mutations in chloroquine and antifolate drug resistance associated genes in complicated and uncomplicated Plasmodium vivax isolates from Chandigarh, North India.
    Kaur H; Sehgal R; Kumar A; Bharti PK; Bansal D; Mohapatra PK; Mahanta J; Sultan AA
    BMC Infect Dis; 2020 Sep; 20(1):671. PubMed ID: 32933490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of Mutations Associated with Antifolate and Chloroquine Resistance among Imported
    Bansal D; Acharya A; Bharti PK; Abdelraheem MH; Elmalik A; Abosalah S; Khan FY; ElKhalifa M; Kaur H; Mohapatra PK; Sehgal R; Idris MA; Mahanta J; Singh N; Babiker HA; Sultan AA
    Am J Trop Med Hyg; 2017 Dec; 97(6):1797-1803. PubMed ID: 29016333
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular surveillance of pvdhfr, pvdhps, and pvmdr-1 mutations in Plasmodium vivax isolates from Yunnan and Anhui provinces of China.
    Huang B; Huang S; Su XZ; Tong X; Yan J; Li H; Lu F
    Malar J; 2014 Sep; 13():346. PubMed ID: 25179752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutations in the antifolate drug resistance marker genes among Plasmodium vivax isolates exhibiting severe manifestations.
    Garg S; Saxena V; Lumb V; Pakalapati D; Boopathi PA; Subudhi AK; Chowdhury S; Kochar SK; Kochar DK; Sharma YD; Das A
    Exp Parasitol; 2012 Dec; 132(4):410-6. PubMed ID: 23043980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance genes: pvcrt-o and pvmdr-1 polymorphism in patients from malaria endemic South Western Coastal Region of India.
    Joy S; Mukhi B; Ghosh SK; Achur RN; Gowda DC; Surolia N
    Malar J; 2018 Jan; 17(1):40. PubMed ID: 29351800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the in vitro sensitivity with associated drug resistance polymorphisms in Plasmodium vivax clinical isolates from Delhi, India.
    Matlani M; Kumar A; Singh V
    Exp Parasitol; 2021 Jan; 220():108047. PubMed ID: 33221328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and patterns of antifolate and chloroquine drug resistance markers in Plasmodium vivax across Pakistan.
    Khattak AA; Venkatesan M; Khatoon L; Ouattara A; Kenefic LJ; Nadeem MF; Nighat F; Malik SA; Plowe CV
    Malar J; 2013 Sep; 12():310. PubMed ID: 24007534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of molecular markers associated with drug resistance of Plasmodium vivax isolates in Western Yunnan Province, China.
    Wang X; Ruan W; Zhou S; Feng X; Yan H; Huang F
    BMC Infect Dis; 2020 Apr; 20(1):307. PubMed ID: 32334523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance markers in Plasmodium vivax isolates from a Kanchanaburi province, Thailand between January to May 2023.
    Sridapan T; Rattanakoch P; Kijprasong K; Srisutham S
    PLoS One; 2024; 19(7):e0304337. PubMed ID: 38968216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of polymorphisms in antifolate drug resistance molecular marker genes pvdhfr and pvdhps in clinical isolates of Plasmodium vivax from Kolkata, India.
    Ganguly S; Saha P; Chatterjee M; Maji AK
    Antimicrob Agents Chemother; 2014; 58(1):196-200. PubMed ID: 24145518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of potential drug resistant molecular markers in Plasmodium vivax from China-Myanmar border during 2008‒2017.
    Wang Z; Wei C; Pan Y; Wang Z; Ji X; Chen Q; Zhang L; Wang Z; Wang H
    Infect Dis Poverty; 2022 Apr; 11(1):43. PubMed ID: 35462549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular surveillance for drug resistance markers in Plasmodium vivax isolates from symptomatic and asymptomatic infections at the China-Myanmar border.
    Zhao Y; Wang L; Soe MT; Aung PL; Wei H; Liu Z; Ma T; Huang Y; Menezes LJ; Wang Q; Kyaw MP; Nyunt MH; Cui L; Cao Y
    Malar J; 2020 Aug; 19(1):281. PubMed ID: 32758218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine.
    Barnadas C; Tichit M; Bouchier C; Ratsimbasoa A; Randrianasolo L; Raherinjafy R; Jahevitra M; Picot S; Ménard D
    Malar J; 2008 Feb; 7():35. PubMed ID: 18302746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.
    Kinzer MH; Chand K; Basri H; Lederman ER; Susanti AI; Elyazar I; Taleo G; Rogers WO; Bangs MJ; Maguire JD
    Malar J; 2010 Apr; 9():89. PubMed ID: 20370920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.
    Barnadas C; Ratsimbasoa A; Tichit M; Bouchier C; Jahevitra M; Picot S; Ménard D
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4233-40. PubMed ID: 18809933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of drug resistance molecular markers in Plasmodium vivax before and after introduction of dihydroartemisinin and piperaquine in Thailand: 2009-2019.
    Suphakhonchuwong N; Rungsihirunrat K; Kuesap J
    Parasitol Res; 2023 Dec; 122(12):2871-2883. PubMed ID: 37725258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017.
    Rakmark K; Awab GR; Duanguppama J; Boonyuen U; Dondorp AM; Imwong M
    Malar J; 2020 Jul; 19(1):251. PubMed ID: 32664924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular evaluation of pvdhfr and pvmdr-1 mutants in Plasmodium vivax isolates after treatment with sulfadoxine/pyrimethamine and chloroquine in Iran during 2001-2016.
    Parsaei M; Raeisi A; Spotin A; Shahbazi A; Mahami-Oskouei M; Hazratian T; Khorashad AS; Zaman J; Bazmani A; Sarafraz S
    Infect Genet Evol; 2018 Oct; 64():70-75. PubMed ID: 29929007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo therapeutic efficacy of chloroquine alone or in combination with primaquine against vivax malaria in Kolkata, West Bengal, India, and polymorphism in pvmdr1 and pvcrt-o genes.
    Ganguly S; Saha P; Guha SK; Das S; Bera DK; Biswas A; Kundu PK; Saha B; Ray K; Maji AK
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1246-51. PubMed ID: 23262997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular surveillance of drug-resistant Plasmodium vivax using pvdhfr, pvdhps and pvmdr1 markers in Nouakchott, Mauritania.
    Mint Lekweiry K; Ould Mohamed Salem Boukhary A; Gaillard T; Wurtz N; Bogreau H; Hafid JE; Trape JF; Bouchiba H; Ould Ahmedou Salem MS; Pradines B; Rogier C; Basco LK; Briolant S
    J Antimicrob Chemother; 2012 Feb; 67(2):367-74. PubMed ID: 22086859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.